HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability

BackgroundThe integration of human papilloma virus (HPV) into host genome is one of the critical steps that lead to the progression of precancerous lesion into cancer. However, the mechanisms and consequences of such integration events are poorly understood. This study aims to explore those questions by studying high risk HPV16 integration in women with cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (SCC).MethodsSpecifically, HPV integration status of 13 HPV16-infected patients were investigated by ligation-mediated PCR (DIPS-PCR) followed by DNA sequencing.ResultsIn total, 8 HPV16 integration sites were identified inside or around genes associated with cancer development. In particular, the well-studied tumor suppressor genes SCAI was found to be integrated by HPV16, which would likely disrupt its expression and therefore facilitate the migration of tumor. On top of that, we observed several cases of chromosome translocation events coincide with HPV integration, which suggests the existence of chromosome instability. Additionally, short overlapping sequences were observed between viral derived and host derived fragments in viral-cellular junctions, indicating that integration was mediated by micro homology-mediated DNA repair pathway.ConclusionsOverall, our study suggests a model in which HPV16 might contribute to oncogenesis not only by disrupting tumor suppressor genes, but also by inducing chromosome instability.

[1]  J. Doorbar,et al.  Human papillomavirus molecular biology and disease association , 2015, Reviews in medical virology.

[2]  Yusuke Nakamura,et al.  Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations , 2010, Nature Genetics.

[3]  Christopher J. Ott,et al.  A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter , 2008, Journal of cellular and molecular medicine.

[4]  Jurg Ott,et al.  Distribution and characterization of regulatory elements in the human genome. , 2002, Genome research.

[5]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[6]  Melissa A. Brown,et al.  Regulates IL-4 Gene Locus Accessibility in An Intron Transcriptional Enhancer Element , 2000 .

[7]  M. Hoeckel,et al.  A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques , 2003, Oncogene.

[8]  X. Fang,et al.  Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism , 2015, Nature Genetics.

[9]  Y. Qiao,et al.  Human papillomavirus type distribution in women from Asia: a meta‐analysis , 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[10]  F. Radvanyi,et al.  MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors , 2006, Oncogene.

[11]  R. Grosse,et al.  Functional Interaction of SCAI with the SWI/SNF Complex for Transcription and Tumor Cell Invasion , 2013, PloS one.

[12]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[13]  M. Machiela,et al.  Genomic characterization of viral integration sites in HPV‐related cancers , 2016, International journal of cancer.

[14]  Dan Chen,et al.  Analysis of Intron Sequence Features Associated with Transcriptional Regulation in Human Genes , 2012, PloS one.

[15]  Sam W. Lee.  H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer , 1996, Nature Medicine.

[16]  G. Nuovo,et al.  Evidence of disrupted high-risk human papillomavirus DNA in morphologically normal cervices of older women , 2016, Scientific Reports.

[17]  M. Levrero,et al.  TP63 and TP73 in cancer, an unresolved “family” puzzle of complexity, redundancy and hierarchy , 2014, FEBS letters.

[18]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[19]  D. Cooper,et al.  Identification of an intronic regulatory element in the human protein C (PROC) gene , 2000, Human Genetics.

[20]  Geir Kjetil Sandve,et al.  Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis , 2015, PloS one.

[21]  Xiaojie Huang,et al.  Distribution of HPV genotypes in Shanghai women. , 2015, International journal of clinical and experimental pathology.

[22]  Christopher J. Ott,et al.  Intronic enhancers coordinate epithelial-specific looping of the active CFTR locus , 2009, Proceedings of the National Academy of Sciences.

[23]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[24]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Braun,et al.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.

[26]  I. Runnebaum,et al.  Loss of gene function as a consequence of human papillomavirus DNA integration , 2012, International journal of cancer.

[27]  S. Schwartz,et al.  Identification of Human Papillomavirus Type 16 L1 Surface Loops Required for Neutralization by Human Sera , 2006, Journal of Virology.

[28]  Y. Hata,et al.  RASSF6; the Putative Tumor Suppressor of the RASSF Family , 2015, Cancers.

[29]  Neva C. Durand,et al.  A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.

[30]  Y. Kodera,et al.  CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer , 2004, British Journal of Cancer.

[31]  Mark Johnson,et al.  NCBI BLAST: a better web interface , 2008, Nucleic Acids Res..

[32]  Melissa A. Brown,et al.  Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene. , 2005, Genomics.

[33]  G. Orfanoudakis,et al.  Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia , 2015, Journal of medical virology.

[34]  M. Mravunac,et al.  Transition of high‐grade cervical intraepithelial neoplasia to micro‐invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities , 2004, The Journal of pathology.

[35]  Zhiyuan Shen.  Genomic instability and cancer: an introduction. , 2011, Journal of molecular cell biology.

[36]  E. Kremmer,et al.  SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of β1-integrin , 2009, Nature Cell Biology.

[37]  J. Fryns,et al.  Human chromosome fragility. , 2008, Biochimica et biophysica acta.

[38]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[39]  Evan Bolton,et al.  Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..

[40]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[41]  G. Tonon,et al.  p63 sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling , 2015, Proceedings of the National Academy of Sciences.

[42]  S. Vowler,et al.  N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype , 2014, Oncogene.

[43]  Ning Ma,et al.  BLAST: a more efficient report with usability improvements , 2013, Nucleic Acids Res..

[44]  L. Hesson,et al.  RASSF6 is a novel member of the RASSF family of tumor suppressors , 2007, Oncogene.

[45]  T. Ishida,et al.  Human papillomavirus genotypes and cervical cancer in northeast Thailand. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[46]  F. E. Yoder,et al.  Chromosome fragile sites. , 1985, Cancer genetics and cytogenetics.

[47]  A. McBride,et al.  Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome , 2014, PLoS pathogens.

[48]  A. Nakao,et al.  Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer , 2004, Cancer science.

[49]  Ming Li,et al.  Dr.VIS v2.0: an updated database of human disease-related viral integration sites in the era of high-throughput deep sequencing , 2014, Nucleic Acids Res..

[50]  E. Flores.  The Roles of p63 in Cancer , 2007, Cell cycle.

[51]  P. Kondaiah,et al.  Regulation of protumorigenic pathways by Insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis , 2013, Molecular Cancer.

[52]  Yanbing Ma,et al.  Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China , 2016, Scientific Reports.

[53]  C. Woodman,et al.  Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. , 2009, Cancer research.

[54]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[55]  I. Xenarios,et al.  UniProtKB/Swiss-Prot, the Manually Annotated Section of the UniProt KnowledgeBase: How to Use the Entry View. , 2016, Methods in molecular biology.

[56]  A. Andreeva,et al.  Cadherin 13 in cancer , 2010, Genes, chromosomes & cancer.

[57]  Francesca Chiaromonte,et al.  A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.

[58]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[59]  C. Woodman,et al.  The natural history of cervical HPV infection: unresolved issues , 2007, Nature Reviews Cancer.

[60]  Satoshi Yamashita,et al.  Estimation of the Fraction of Cancer Cells in a Tumor DNA Sample Using DNA Methylation , 2013, PloS one.

[61]  Lars Jansen,et al.  Non-Random Integration of the HPV Genome in Cervical Cancer , 2012, PloS one.

[62]  David Altshuler,et al.  Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus , 2008, Nature Genetics.

[63]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[64]  M. Bartelmann,et al.  APM‐1, a novel human gene, identified by aberrant co‐transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ‐zinc finger protein with growth inhibitory activity , 1998, The EMBO journal.

[65]  N. Coleman,et al.  An increase in DNA double‐strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events , 2007, The Journal of pathology.

[66]  Yuguang Shi,et al.  SNX25 regulates TGF-β signaling by enhancing the receptor degradation. , 2011, Cellular signalling.

[67]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[68]  A. Ridley.  Rho Proteins and Cancer , 2004, Breast Cancer Research and Treatment.

[69]  Y. Hata,et al.  The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and the Cell Cycle via MDM2 Protein and p53 Protein* , 2013, The Journal of Biological Chemistry.

[70]  E. Domingo,et al.  Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia , 2013, International Journal of Gynecologic Cancer.

[71]  Bi-Jun Huang,et al.  Downregulation of Ras Association Domain Family Member 6 (RASSF6) Underlies the Treatment Resistance of Highly Metastatic Nasopharyngeal Carcinoma Cells , 2014, PloS one.

[72]  Meenakshi Malhotra,et al.  Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition , 2015, Seminars in cancer biology.